drugset

drugset / Trial / NCT07021963

A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

NCT07021963 ↗

Phase 2 Recruiting 300 enrolled Shandong Suncadia Medicine Co., Ltd.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.

Timeline

Start: 2025-07-04
Primary completion: 2027-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-1893	Unknown	—	—

Indications